Condition: Obesity & Overweight · Obesity · Genetics · Sponsor: Jan Kochanowski University
This study will assess the impact of genetic markers, microbiological (microbiome) and behavioral factors on tolerance, adherence and effectiveness of dual GLP1/GIP RA in the treatment of obesity. 200 consecutive patients who meet all inclusion and none of the exclusion criteria will be enrolled.
This description comes directly from the study's public registry record.
Zbigniew Siudak PI, MD, PhD · +48 41 349 6972 · zbigniew.siudak@ujk.edu.pl
Always discuss trial participation with your own doctor first.
| Waga Zmiany | Krakow, Poland | Recruiting |
| Luxmed sp zoo | Warsaw, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07650149